Current through Register Vol. 35, No. 18, September 24, 2024
A. The board shall monitor the dispensing of all schedule II - V controlled substances and drug(s) of concern by all dispensers licensed to dispense such substances to patients in this state.
B. Each dispenser shall submit to the board by electronic means information regarding each prescription dispensed for a drug included under Subsection A of this section. Information to be submitted for each prescription as well as the standards for how this information shall be formatted, not contrary to law, is defined in the PMP data reporting manual available on the state PMP website at http://nmpmp.org shall include at a minimum:
(1) dispenser NPI number;
(2) dispenser NCPDP number;
(3) dispenser DEA number (unless no controlled substances are dispensed and dispenser has no DEA number);
(4) patient name;
(5) patient address;
(6) patient date of birth;
(7) patient gender;
(8) reporting status (new, revised, void);
(9) prescription number;
(10) date prescription written;
(11) refills authorized;
(12) date prescription filled;
(13) refill number;
(14) product ID (NDC) + product ID qualifier;
(15) quantity dispensed;
(16) days' supply;
(17) drug dosage units;
(18) transmission form of Rx origin;
(19) payment type;
(20) prescriber NPI number; (except veterinarians)
(21) prescriber DEA number (unless prescriber is prescribing a drug of concern and has no DEA number)
C. Dispenser reporting:
(1) each dispenser shall submit the information required under Subsection B of this section in accordance with transmission methods and frequency established by the board; but shall report within one business day of the prescription being filled.
(2) if a dispenser pharmacy did not dispense any schedule II - V controlled substances or drug(s) of concern during an operating business day, the dispenser shall submit a "zero report" within one business day. Information to be submitted with each zero report as well as the standards for how this information shall be formatted, not contrary to law, is defined in the PMP data reporting manual available on the state PMP website at
http://nmpmp.org shall include at a minimum:
(a) dispenser DEA number;
(b) reporting start date; and
(c) reporting end date.
(3) the PMP director shall have the authority to approve submission schedules that exceed one business day.
D. Corrections to information submitted to the PMP must be addressed including:
(1) file upload or "outstanding uncorrected errors" as defined in the PMP data reporting manual;
(2) prescriptions that were not dispensed to the patient must be voided from the PMP;
(3) incorrect information in prescriptions records submitted to the PMP must be submitted to the PMP database within five business days once the dispenser has been notified or becomes aware of the incorrect information.
